LEXTF - Lexston Life Sciences Corp.
From OTC Wiki
Lexston Life Sciences is Granted Section 56 Exemption from Health Canada and embarks on the development of portable technology for quantification and traceability of Psilocybe mushrooms
Mon, 00:00 January 31, 2022 | WikiVisor
Mon, 00:00 January 24, 2022 | WikiVisor
Lexston Announces Federal Funding for Cannabis Transformation Project That Will Result in Zero THC Varieties.
Wed, 00:00 January 19, 2022 | WikiVisor
Fri, 00:00 January 14, 2022 | WikiVisor
Lexston Announces a Memorandum Of Understanding to Collabborate on Psychedelics Research and Development with Alvarius Research Inc.
Wed, 00:00 January 12, 2022 | WikiVisor
More News: Company News | OTC Markets
LEXTF Profile by TradingView
Lexston Life Sciences Corp. by TradingView
- Lexston Life Sciences Corp - March 15, 2022: Company website
- Twitter - March 1, 2022:
No opinions so far.
Please login or register to post your opinion.